Correlation Between Kiora Pharmaceuticals and Viracta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Viracta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Viracta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Viracta Therapeutics, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Viracta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Viracta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Viracta Therapeutics.
Diversification Opportunities for Kiora Pharmaceuticals and Viracta Therapeutics
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Kiora and Viracta is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Viracta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viracta Therapeutics and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Viracta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viracta Therapeutics has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Viracta Therapeutics go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Viracta Therapeutics
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 0.2 times more return on investment than Viracta Therapeutics. However, Kiora Pharmaceuticals is 5.06 times less risky than Viracta Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Viracta Therapeutics is currently generating about -0.49 per unit of risk. If you would invest 391.00 in Kiora Pharmaceuticals on November 18, 2024 and sell it today you would lose (29.00) from holding Kiora Pharmaceuticals or give up 7.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 66.67% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Viracta Therapeutics
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Viracta Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Kiora Pharmaceuticals and Viracta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Viracta Therapeutics
The main advantage of trading using opposite Kiora Pharmaceuticals and Viracta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Viracta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viracta Therapeutics will offset losses from the drop in Viracta Therapeutics' long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Viracta Therapeutics vs. Vincerx Pharma | Viracta Therapeutics vs. Rallybio Corp | Viracta Therapeutics vs. Tenaya Therapeutics | Viracta Therapeutics vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |